Perceptive Advisors’s West Pharmaceutical WST Stock Holding History

Perceptive Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-138	Closed	-$11K	–	156
2017 Q1	$11K	Hold	138	–	–	﹤0.01%	149
2016 Q4	$12K	Buy	+138	New	+$10.9K	﹤0.01%	160

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Perceptive Advisors's WST Position: Q2 2017 in Review

Perceptive Advisors sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 138 shares — an estimated $11K sold.

Perceptive Advisors first reported a position in WST in Q4 2016 and held it in 2 quarters. The position peaked at $12K in Q4 2016. 310 funds tracked by Wall St. Rank hold WST as of Q2 2017.

Perceptive Advisors reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
Perceptive Advisors sold 138 West Pharmaceutical shares in Q2 2017, an estimated $11K.
Perceptive Advisors first reported a position in West Pharmaceutical in Q4 2016 and held it in 2 quarters.
Perceptive Advisors's West Pharmaceutical position peaked at $12K in Q4 2016.
310 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.